Dynavax Technologies Corp. Company Profile (NASDAQ:DVAX)

Analyst Ratings

Consensus Ratings for Dynavax Technologies Corp. (NASDAQ:DVAX) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $35.25 (135.00% upside)

Analysts' Ratings History for Dynavax Technologies Corp. (NASDAQ:DVAX)
Show:
DateFirmActionRatingPrice TargetActions
4/28/2016Cowen and CompanyReiterated RatingBuy$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016Royal Bank Of CanadaDowngradeOutperform -> Sector Perform$48.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2016JPMorgan Chase & Co.DowngradeOverweight -> Neutral$29.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2015William BlairReiterated RatingOutperform$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for Dynavax Technologies Corp. (NASDAQ:DVAX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/5/2016        
5/9/2016Q1($0.63)($0.70)$627.00 million$942.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q4($0.75)($0.70)$1.15 million$0.69 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q3($0.78)($0.82)$1.65 million$1.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2015Q2($1.00)($0.80)$3.05 million$1.55 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015($0.95)($0.97)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2015($1.06)($0.85)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q314($0.09)($0.11)$2.50 million$2.21 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.06)($0.09)$2.26 million$3.05 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2014($0.06)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2014Q413($0.07)($0.09)$1.56 million$2.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.10)($0.09)$1.83 million$2.93 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2013Q2 2013($0.10)($0.09)$2.91 million$3.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2013Q113($0.11)($0.11)$2.40 million$2.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2013Q4 2012($0.11)$11.40 million$1.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312($0.08)($0.10)$5.00 million$2.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dynavax Technologies Corp. (NASDAQ:DVAX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.52)($0.52)($0.52)
Q2 20161($0.68)($0.68)($0.68)
Q3 20161($0.68)($0.68)($0.68)
Q4 20161($0.72)($0.72)($0.72)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Dynavax Technologies Corp. (NASDAQ:DVAX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Dynavax Technologies Corp. (NASDAQ:DVAX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/28/2016Robert JanssenVPBuy1,452$13.68$19,863.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Eddie GrayCEOBuy2,750$15.57$42,817.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016Robert JanssenVPBuy1,000$15.12$15,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2014Eddie GrayCEOBuy25,000$1.49$37,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2013Peggy V PhillipsDirectorBuy93,023$1.08$100,464.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2012Jennifer LewVPSell18,750$4.53$84,937.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2012Robert CoffmanVPSell8,000$4.52$36,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Dynavax Technologies Corp. (NASDAQ:DVAX)
DateHeadline
07/26/16 07:48 AMDynavax Technologies Corporation (DVAX) Shares are Up 1.26% - Trade Calls
07/24/16 03:31 PMIs $45 Price Target Attainable For Dynavax Technologies Corporation (NASDAQ:DVAX)? - Investor Newswire
07/23/16 07:49 AMWill Dynavax Technologies Corporation Go Down Anytime Soon? - Consumer Eagle
07/23/16 07:49 AMEquity Roundup: Stock Performance Focus on Dynavax Technologies Corporation (NASDAQ:DVAX) - Press Telegraph
07/23/16 07:49 AMDynavax Technologies Corporation (NASDAQ:DVAX): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/22/16 07:06 AMDynavax Technologies Corp. breached its 50 day moving average in a Bullish Manner : DVAX-US : July 22, 2016 -
07/21/16 07:10 AMDynavax Technologies Corporation (DVAX) Jumps 5.47% on July 20 - Equities.com
07/18/16 03:49 PMInvestor Watch: Volatility Recap on Shares of: Dynavax Technologies Corporation (NASDAQ:DVAX) - Engelwood Daily
07/18/16 03:49 PMShare Performance Summary for: Dynavax Technologies Corporation (NASDAQ:DVAX) - Press Telegraph
07/18/16 03:49 PMNews review of 2 biotech stocks: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Dynavax Technologies ... - The Voice Registrar
07/18/16 02:40 PMDynavax Technologies Corp. – Value Analysis (NASDAQ:DVAX) : July 18, 2016 -
07/18/16 08:47 AMShares of Dynavax Technologies Corporation (DVAX) Drops by -2.32% - Trade Calls
07/17/16 08:14 AMShares Moving Down on the Week: Dynavax Technologies Corporation (NASDAQ:DVAX) - Engelwood Daily
07/17/16 08:14 AMNext Weeks Broker Price Targets For Dynavax Technologies Corporation (DVAX) - Fiscal Standard
07/16/16 07:08 AMShares Experiencing a Downtrend: Dynavax Technologies Corporation (NASDAQ:DVAX) - TGP
07/16/16 07:07 AMDynavax Technologies Corporation (DVAX) Jumps 6.32% on July 15 - Equities.com
07/15/16 06:49 AMDynavax Tech Corporation (NASDAQ:DVAX) Shorted Shares Decreased By 0.8% - Consumer Eagle
07/15/16 06:49 AMDynavax Technologies Corporation (NASDAQ:DVAX) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/15/16 06:49 AMAnalyst Target and Average Rating Watch: Dynavax Technologies Corporation (NASDAQ:DVAX) - Press Telegraph
07/15/16 06:49 AMDynavax Technologies Corporation Realized Volatility Hits Elevated Level - CML News
07/14/16 03:56 PMTrading Performance and Target Watch for Dynavax Technologies Corporation (NASDAQ:DVAX) - Press Telegraph
07/13/16 03:55 PMDynavax Technologies Corporation (NASDAQ:DVAX) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/13/16 03:55 PMBroker Outlook For Dynavax Technologies Corporation (DVAX) - Fiscal Standard
07/12/16 08:00 AMStock Rating Watch and Earnings Insight for Dynavax Technologies Corporation (NASDAQ:DVAX) - Press Telegraph
07/12/16 08:00 AMIs $45 Within Reach For Dynavax Technologies Corporation (NASDAQ:DVAX)? - Investor Newswire
07/12/16 08:00 AMHC Stocks Overview: HeartWare International Inc (NASDAQ:HTWR), Dynavax Technologies Corporation (NASDAQ ... - share market updates (press release)
07/11/16 07:37 AMDynavax Technologies Corp. breached its 50 day moving average in a Bullish Manner : DVAX-US : July 11, 2016 -
07/10/16 08:15 AMDynavax Technologies Corporation (DVAX) Broker Price Targets For The Coming Week - Fiscal Standard
07/09/16 04:54 PMWhy Dynavax Technologies Shares Slid 12% in June - Investors continue to sit on the sidelines after the FDA delayed a decision on its hepatitis B vaccine in April.
07/09/16 07:12 AMCompany Stock Focus for Dynavax Technologies Corporation (NASDAQ:DVAX): Which Way Will Shares Head? - Press Telegraph
07/09/16 07:12 AMDynavax Technologies Corp (NASDAQ:DVAX) Institutional Investor Sentiment - Engelwood Daily
07/07/16 07:34 AMDynavax Technologies Corporation (NASDAQ:DVAX) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/07/16 07:34 AMInsiders Increasing Positions in: Dynavax Technologies Corporation (NASDAQ:DVAX) - Press Telegraph
07/07/16 07:34 AMDynavax Technologies Corporation (DVAX) : Analyst Rating Update - Trade Calls
07/04/16 03:27 PMBroker Outlook For The Week Ahead Dynavax Technologies Corporation (DVAX) - Fiscal Standard
07/02/16 07:10 AMCan Dynavax Technologies Corporation (NASDAQ:DVAX) Meet Analysts Expectations? - Stocks Daily
06/28/16 08:46 PMDynavax Technologies Corporation (NASDAQ:DVAX) Company Rating and Target Watch - Telanagana Press
06/28/16 03:40 PMHow Analysts Feel About Dynavax Technologies Corporation (NASDAQ:DVAX)? - Press Telegraph
06/28/16 03:40 PMHow Analysts Feel About Dynavax Technologies Corporation (NASDAQ:DVAX)? - Press Telegraph
06/28/16 08:36 AM29 Biotechnology Stocks to Sell Now - Investorplace.com
06/28/16 08:36 AMActive Watch List: TE Connectivity Ltd. (NYSE:TEL), Dynavax Technologies Corporation (NASDAQ:DVAX), Provectus ... - KC Register
06/28/16 08:36 AMShare Update and Earnings Review for Dynavax Technologies Corporation (NASDAQ:DVAX) - Press Telegraph
06/24/16 10:28 AMCovering the Bases on Dynavax Technologies Corporation (NASDAQ:DVAX): Where is the Stock Going? - Press Telegraph
06/23/16 02:39 PMCan Dynavax Technologies Corporation (NASDAQ:DVAX) Surprise Analysts this Quarter? - Investor Newswire
06/23/16 07:18 AMDynavax Technologies Corporation (DVAX) Current Analyst Ratings - Fiscal Standard
06/21/16 03:30 PMDynavax Technologies Corporation (NasdaqCM:DVAX) Stock Momentum Hits Extreme Weakness - CML News
06/20/16 03:37 PMCompany Shares of Dynavax Technologies Corporation Drops by -2.19% - Trade Calls
06/15/16 03:46 PMDynavax's HEPLISAV-B beats Glaxo's ENGERIX-B in late-stage study - Seeking Alpha
06/15/16 03:46 PMBiotech Forum Daily Digest: Heading Down; Valeant's Plan; What I Am Buying Now - Seeking Alpha
06/15/16 08:29 AMForm 8-K DYNAVAX TECHNOLOGIES For: Jun 11 - StreetInsider.com

Social

About Dynavax Technologies Corp.

Dynavax Technologies Corp. logoDynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company. The Company uses toll-like receptor (TLR) biology to discover and develop vaccines and therapeutics. Its development programs are focused on vaccines and cancer immunotherapy. The Company's lead vaccine product candidate is HEPLISAV-B, an investigational adult hepatitis B vaccine, which combines its TLR9 agonist adjuvant and recombinant hepatitis B surface antigen (rHBsAg). Its lead cancer immunotherapy candidate is SD-101, a C Class CpG TLR9 agonist is selected for characteristics optimal for treatment of cancer, including high interferon induction. Its SD-101 clinical program is intended to assess the preliminary efficacy of SD-101 in a range of tumors and in combination with a range of treatments. Its advanced inflammatory disease candidate is AZD1419. Its pipeline of product candidates for cancer immunotherapy includes DV281 and CpG-Nanoparticles, which are in the preclinical stage.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: DVAX
  • CUSIP: 26815810
Key Metrics:
  • Previous Close: $15.32
  • 50 Day Moving Average: $14.86
  • 200 Day Moving Average: $18.02
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $577.43M
  • Beta: 2.47
  • Current Year EPS Consensus Estimate: $-2.82 EPS
  • Next Year EPS Consensus Estimate: $-1.96 EPS
Additional Links:
Dynavax Technologies Corp. (NASDAQ:DVAX) Chart for Tuesday, July, 26, 2016